Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Condition

Peptostreptococcus species

4

Unknown

2,578

Pain

614

Cancer

592

Hypertension

567

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

US Approved Rx

4

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Beta-lactamase TEM

4

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

4

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1986

4

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Curative

4

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

4

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

4

ChEMBL

4

EPA CompTox

4

FDA UNII

4

NCI_THESAURUS

4

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTIINFECTIVES FOR SYSTEMIC USE

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTIBACTERIALS FOR SYSTEMIC USE

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

BETA-LACTAM ANTIBACTERIALS, PENICILLINS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Beta-lactamase inhibitors

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

3

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 4 of 4 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

SULBACTAM

S4TF6I2330

Export Data
Search for Structure

Status:

US Approved Rx (2010)

First approved in 1986

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Beta-lactamase TEM

Conditions:

Staphylococcus aureus (beta-lactamase and non-beta-lactamase producing)

Staphylococcus epidermidis (beta-lactamase and non-beta-lactamase producing)

Moraxella (Branhamella) catarrhalis (beta-lactamase and non-beta-lactamase producing)

Bacterial infections

Peptostreptococcus species

Hemophilus influenzae (beta-lactamase and non-beta-lactamase producing)

Sulbactam is a β-lactamase inhibitor given in combination with β-lactam antibiotics to inhibit β-lactamase, an enzyme produced by bacteria that destroys the antibiotics. Sulbactam in combination with semisynthetic antibiotic ampicillin sodium is indi...

cated for the treatment of infections due to susceptible strains of the designated microorganisms: Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli etc; Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp. (including K. Pneumoniae) tec; Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli, and Bacteroides spp. (including B. fragilis).

SULBACTAM BENZATHINE

49MU89FVBV

Export Data
Search for Structure

Status:

US Approved Rx (2010)

First approved in 1986

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Beta-lactamase TEM

Conditions:

Staphylococcus aureus (beta-lactamase and non-beta-lactamase producing)

Staphylococcus epidermidis (beta-lactamase and non-beta-lactamase producing)

Moraxella (Branhamella) catarrhalis (beta-lactamase and non-beta-lactamase producing)

Bacterial infections

Peptostreptococcus species

Hemophilus influenzae (beta-lactamase and non-beta-lactamase producing)

Sulbactam is a β-lactamase inhibitor given in combination with β-lactam antibiotics to inhibit β-lactamase, an enzyme produced by bacteria that destroys the antibiotics. Sulbactam in combination with semisynthetic antibiotic ampicillin sodium is indi...

cated for the treatment of infections due to susceptible strains of the designated microorganisms: Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli etc; Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp. (including K. Pneumoniae) tec; Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli, and Bacteroides spp. (including B. fragilis).

SULBACTAM SODIUM

DKQ4T82YE6

Export Data
Search for Structure

Status:

US Approved Rx (2010)

First approved in 1986

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Beta-lactamase TEM

Conditions:

Staphylococcus aureus (beta-lactamase and non-beta-lactamase producing)

Staphylococcus epidermidis (beta-lactamase and non-beta-lactamase producing)

Moraxella (Branhamella) catarrhalis (beta-lactamase and non-beta-lactamase producing)

Bacterial infections

Peptostreptococcus species

Hemophilus influenzae (beta-lactamase and non-beta-lactamase producing)

Sulbactam is a β-lactamase inhibitor given in combination with β-lactam antibiotics to inhibit β-lactamase, an enzyme produced by bacteria that destroys the antibiotics. Sulbactam in combination with semisynthetic antibiotic ampicillin sodium is indi...

cated for the treatment of infections due to susceptible strains of the designated microorganisms: Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli etc; Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp. (including K. Pneumoniae) tec; Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli, and Bacteroides spp. (including B. fragilis).

SULBACTAM PIVOXIL

2X0WTA96KX

Export Data
Search for Structure

Status:

US Approved Rx (2010)

First approved in 1986

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Beta-lactamase TEM

Conditions:

Staphylococcus aureus (beta-lactamase and non-beta-lactamase producing)

Staphylococcus epidermidis (beta-lactamase and non-beta-lactamase producing)

Moraxella (Branhamella) catarrhalis (beta-lactamase and non-beta-lactamase producing)

Bacterial infections

Peptostreptococcus species

Hemophilus influenzae (beta-lactamase and non-beta-lactamase producing)

Sulbactam is a β-lactamase inhibitor given in combination with β-lactam antibiotics to inhibit β-lactamase, an enzyme produced by bacteria that destroys the antibiotics. Sulbactam in combination with semisynthetic antibiotic ampicillin sodium is indi...

cated for the treatment of infections due to susceptible strains of the designated microorganisms: Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli etc; Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp. (including K. Pneumoniae) tec; Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli, and Bacteroides spp. (including B. fragilis).

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1